Abstract
The main experimental animal model for human diabetes has been the alloxan - or streptozotocin-treated animal. Such preparations resemble human type I or insulin-dependent diabetes. Recently a rat model has been introduced that exhibits characteristics of type n or insulin-independent diabetes. This is the SHR/N-cp rat developed by C.T. Hansen at the National Institutes of Health (1) and studied in detail by Michaelis et al.(2). This animal is obese, hyperinsulinemic and hyperlipidemic. The fasting blood sugar is only slightly elevated, but the glucose tolerance curve is markedly abnormal. The diabetes manifested in this animal is thus caused not by a lack of insulin but rather by resistance to the action of the hormone. Hypertension is absent in young rats but develops slowly with age. A genetically related animal, the LA/N-lean rat, is not diabetic and is used as a control in the studies reported here. In our recent investigations of the effect of diabetes on metabolism we have used these animal models as well as the streptozotocin-diabetic rat. Our experiments have centered around glycogen metabolism, and because of the involvement of uracil nucleotides in the synthesis of glycogen, the metabolism of these intermediates has also been studied.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hansen, C.T. Fed. Proc, 42:537, 1983.
Michaelis, O.E. Jr. Am. J. Clin. Nutr. 39:612–618, 1984.
Puis, W., Keup, U., Krause, H.P., Thomas, G. and Hoffmeister, F. Naturwissenschaffen 64:536–537, 1977.
Vaselli, J.R., Haraczkiewicz, E. and Pi-Sunyer, F.X. Nutr. Behav. 1:21–32, 1982.
Cruiekshank, M.B. J. Physiol. 47:1–14,1913.
Shipp, J.C, Opie, L.H. and Challoner, D. Nature, London 189:1018–1019, 1961.
Randle, P.J., Newsholme, E.A. and Garland, P.B. Biochem. J. 93:652–665, 1964.
Haugaard, N., Hess, M.E., Locke, C.L., Torbati, A. and Wildey, G. Biochem. Pharmacol. 33:1503–1508, 1984.
Hess, M.E., Haugaard, N., Min, W. and Torbati, A. Arch int. Pharmacodyn. In Press.
Shipp, J.C. Metabolism 13:852–866, 1964.
Opie, L.H. Am. Heart J. 77:383–410, 1969.
Haugaard, E.S., Frantz, K.B. and Haugaard, N. Proc. nat. Acad. Sci. U.S.A., 74:2339–2342, 1977.
Gertz, B.J. and Haugaard, E.S. Metabolism, 28:358–362, 1979.
Songu, E., Haugaard, E.S., Wildey, G. and Haugaard, N. Metabolism 30:119–122, 1981.
Aussedat, J. Cardiovas. Res. 17:145–151, 1983.
Regen, D.M., Davis, W.W., Morgan, H.E. and Park, C.R. J. Biol. Chem. 239:43–49, 1964.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Haugaard, N., Hess, M.E., Torbati, A., Tulp, O.L. (1987). Energy Metabolism in Diabetic Heart. In: Dhalla, N.S., Singal, P.K., Beamish, R.E. (eds) Pathophysiology of Heart Disease. Developments in Cardiovascular Medicine, vol 65. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2051-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2051-7_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9219-7
Online ISBN: 978-1-4613-2051-7
eBook Packages: Springer Book Archive